Skip to main content
See every side of every news story
Published loading...Updated

Study reveals genetic impact of Agent Orange on bone marrow cancers

The study shows 54% of Agent Orange-exposed veterans developed myelodysplastic syndromes with more high-risk mutations and 80% higher early disease progression risk.

Summary by News Medical
More than 50 years after Agent Orange was used in Vietnam, a new national study published online ahead of print in Blood Advances highlights the genetic changes that link exposure to Agent Orange to myelodysplastic syndromes (MDS), a group of bone marrow cancers that can progress to acute leukemia.

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

News Medical broke the news in United States on Tuesday, March 24, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal